Thank you, Mr. Chair.
I'm glad to hear about your blood pressure, Mr. Fleury. I am wondering whether we shouldn't be monitoring Mr. Goodman carefully, though, at this point, given his new responsibilities.
Mr. Fleury, when the advisory panel resigned en masse on February 27, they wrote you a letter, and I suspect you knew that was in the works. Had you tried to dissuade them from taking that action prior to their resignations?